As of October 19, thirteen Dogecoin addresses controlled 46.18% of the total DOGE supply recorded in a rich-list snapshot, with the largest address holding over 27 billion DOGE. However, these figures reflect wallet balances, not the number of individual owners, since some addresses may hold coins on behalf of many users, such as custodial wallets like Robinhood's. Excluding one inaccessible burn address, the top 12 addresses still hold about 45% of the supply. This concentration highlights the importance of understanding wallet versus individual ownership in cryptocurrency holdings.
The concentration of Dogecoin supply among a few addresses is the subject here, with 46.18% held by thirteen addresses. For readers following major cryptocurrencies, here is Pluang's market snapshot as of Oct 20, 2026 06:02 WIB: 42 of 50 major cryptocurrencies rose today. Notable movers include SNX at Rp3.868 (+4.20%), UNI at Rp131.773 (+3.10%), and SAND at Rp1.067 (+2.90%).
Dorchester Minerals, L.P. has agreed to acquire mineral and royalty interests covering about 4,300 net royalty acres in three counties within North Dakota's Williston Basin. The deal involves a non-taxable contribution and exchange agreement with an ...
The Hershey Trust Company sold 1,512 common shares under a trading plan but kept voting control through Class B shares. Hershey will report Q3 earnings on October 29, with investors focused on how price increases affected Halloween-season demand. Q2 ...
W. R. Berkley reported mixed Q3 2026 results with earnings per share of $1.17 beating estimates, but revenue fell short at $3.74 billion versus $3.82 billion expected. The company saw premium growth with gross premiums up 3% and net premiums up 1%, s...
GE Aerospace is set to report its Q3 earnings with analysts forecasting a 21.7% rise in earnings per share to $2.02 and nearly 12% revenue growth to about $12.7 billion. Despite consistently beating estimates, the stock has fallen after past reports ...
Silence Therapeutics' stock surged 125.6% to $19.58 following Merck KGaA's agreement to acquire the RNA-interference drug developer for about $1.3 billion in equity value. Merck will pay $20 per share, a 130% premium over the recent closing price. Ot...
